SPL 3.00% 9.7¢ starpharma holdings limited

Blood cancer clinical trials are dropping like flies, page-3

  1. 15,657 Posts.
    lightbulb Created with Sketch. 5718
    Exactly @Biostock ... regardless of what the CEO spruiked in the recent interview and what some on here are claiming about AZD0466 expanding further, people should perhaps temper their expectations because this second trial hasn't even started recruiting yet ... one should maybe ask why given it was set up in January 2022 (6 months ago) ?

    .... but hey it's all rainbows and sunshine in Starpharma's future if some on here are to be believed

    https://www.clinicaltrials.gov/ct2/show/NCT05205161?term=AZD0466&draw=2&rank=2

    upload_2022-7-4_16-45-24.png
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.